Literature DB >> 12097674

Lymphocyte propionyl-CoA carboxylase is an early and sensitive indicator of biotin deficiency in rats, but urinary excretion of 3-hydroxypropionic acid is not.

Donald M Mock1, Nell I Mock.   

Abstract

Recent clinical studies have provided evidence that marginal biotin deficiency is more common than previously thought. The validity of that conclusion rests on two indicators of biotin status that depend on renal function. Our goal was to develop and assess the usefulness of two additional indicators in detecting marginal biotin status in a rat model, i.e., 1) activity of the biotin-dependent enzyme propionyl-CoA carboxylase in lymphocytes; and 2) urinary excretion of 3-hydroxypropionic acid, an organic acid that reflects decreased activity of propionyl-CoA carboxylase. Marginal-to-moderate biotin deficiency was induced experimentally by an egg-white diet (deficient rats); the biotin-supplemented rats were fed the egg-white diet plus supplemental biotin. Propionyl-CoA carboxylase activity was determined by an optimized H(14)CO(3)(-) incorporation assay. Urinary organic acids were determined by gas chromatography/mass spectrometry. Lymphocyte propionyl-CoA carboxylase activity decreased dramatically and in parallel with hepatic propionyl-CoA carboxylase activity. By d 7, lymphocyte propionyl-CoA carboxylase activity in each rat in the deficient group had decreased to less than the lowest value of any rat on d 0. By two-way ANOVA, the effects of diet (P < 0.0001), time (P < 0.005) and their interaction (P < 0.0001) were all significant. The urinary excretion of 3-hydroxypropionic acid did not differ between the two groups. Lymphocyte propionyl-CoA carboxylase activity is an early and sensitive indicator of marginal biotin deficiency, whereas the urinary excretion of 3-hydroxypropionic acid is not.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097674      PMCID: PMC1435358          DOI: 10.1093/jn/132.7.1945

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  26 in total

1.  Indicators of biotin status: a study of patients on prolonged total parenteral nutrition.

Authors:  A Velázquez; S Zamudio; A Báez; R Murguía-Corral; B Rangel-Peniche; A Carrasco
Journal:  Eur J Clin Nutr       Date:  1990-01       Impact factor: 4.016

2.  Distribution of biotin in human plasma: most of the biotin is not bound to protein.

Authors:  D M Mock; M I Malik
Journal:  Am J Clin Nutr       Date:  1992-08       Impact factor: 7.045

3.  The biotin requirement of rats fed 20% egg white.

Authors:  L M Klevay
Journal:  J Nutr       Date:  1976-11       Impact factor: 4.798

4.  Increased urinary excretion of 3-hydroxyisovaleric acid and decreased urinary excretion of biotin are sensitive early indicators of decreased biotin status in experimental biotin deficiency.

Authors:  N I Mock; M I Malik; P J Stumbo; W P Bishop; D M Mock
Journal:  Am J Clin Nutr       Date:  1997-04       Impact factor: 7.045

5.  Biotin in human milk: methods, location, and chemical form.

Authors:  D M Mock; N I Mock; S E Langbehn
Journal:  J Nutr       Date:  1992-03       Impact factor: 4.798

6.  Effect of long-term treatment with antiepileptic drugs on the vitamin status.

Authors:  K H Krause; J P Bonjour; P Berlit; G Kynast; H Schmidt-Gayk; B Schellenberg
Journal:  Drug Nutr Interact       Date:  1988

7.  The effects of biotin deficiency on organic acid metabolism: increase in propionyl coenzyme A-related organic acids in biotin-deficient rats.

Authors:  Y Y Liu; Y Shigematsu; A Nakai; Y Kikawa; M Saito; T Fukui; K Hayakawa; J Oizumi; M Sudo
Journal:  Metabolism       Date:  1993-11       Impact factor: 8.694

8.  Biotin supplementation affects lymphocyte carboxylases and plasma biotin in severe protein-energy malnutrition.

Authors:  A Velázquez; M Terán; A Báez; J Gutiérrez; R Rodríguez
Journal:  Am J Clin Nutr       Date:  1995-02       Impact factor: 7.045

9.  Evidence for a pathogenic role of omega 6 polyunsaturated fatty acid in the cutaneous manifestations of biotin deficiency.

Authors:  D M Mock
Journal:  J Pediatr Gastroenterol Nutr       Date:  1990-02       Impact factor: 2.839

10.  Quantification of urinary 3-hydroxyisovaleric acid using deuterated 3-hydroxyisovaleric acid as internal standard.

Authors:  D M Mock; H Jackson; G L Lankford; N I Mock; S T Weintraub
Journal:  Biomed Environ Mass Spectrom       Date:  1989-09
View more
  15 in total

1.  Development and characterization of a mouse with profound biotinidase deficiency: a biotin-responsive neurocutaneous disorder.

Authors:  Kirit Pindolia; Megan Jordan; Caiying Guo; Nell Matthews; Donald M Mock; Erin Strovel; Miriam Blitzer; Barry Wolf
Journal:  Mol Genet Metab       Date:  2010-10-13       Impact factor: 4.797

2.  Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS/MS as a novel biomarker of biotin status in humans.

Authors:  Thomas D Horvath; Shawna L Stratton; Anna Bogusiewicz; Lindsay Pack; Jeffery Moran; Donald M Mock
Journal:  Anal Chem       Date:  2010-05-15       Impact factor: 6.986

3.  Marginal maternal biotin deficiency in CD-1 mice reduces fetal mass of biotin-dependent carboxylases.

Authors:  Wendy M Sealey; Shawna L Stratton; Donald M Mock; Deborah K Hansen
Journal:  J Nutr       Date:  2005-05       Impact factor: 4.798

4.  Nitric oxide signaling depends on biotin in Jurkat human lymphoma cells.

Authors:  Rocio Rodriguez-Melendez; Janos Zempleni
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

5.  Marginal biotin deficiency is common in normal human pregnancy and is highly teratogenic in mice.

Authors:  Donald M Mock
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

6.  Marginal biotin deficiency is teratogenic in ICR mice.

Authors:  Donald M Mock; Nell I Mock; Christopher W Stewart; James B LaBorde; Deborah K Hansen
Journal:  J Nutr       Date:  2003-08       Impact factor: 4.798

7.  Biotin dependency due to a defect in biotin transport.

Authors:  Rebecca Mardach; Janos Zempleni; Barry Wolf; Martin J Cannon; Michael L Jennings; Sally Cress; Jane Boylan; Susan Roth; Stephen Cederbaum; Donald M Mock
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 8.  Biotin.

Authors:  Janos Zempleni; Subhashinee S K Wijeratne; Yousef I Hassan
Journal:  Biofactors       Date:  2009 Jan-Feb       Impact factor: 6.113

9.  Holocarboxylase synthetase regulates expression of biotin transporters by chromatin remodeling events at the SMVT locus.

Authors:  Michael Gralla; Gabriela Camporeale; Janos Zempleni
Journal:  J Nutr Biochem       Date:  2007-09-27       Impact factor: 6.048

10.  Identification and assessment of markers of biotin status in healthy adults.

Authors:  Wei Kay Eng; David Giraud; Vicki L Schlegel; Dong Wang; Bo Hyun Lee; Janos Zempleni
Journal:  Br J Nutr       Date:  2013-01-10       Impact factor: 3.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.